Tuesday, April 20, 2021 3:04:16 PM
Biotech Medics, Inc. Now Operating Sumcoin Nodes Directly
Press Release | 04/16/2021
WOODLAND HILLS, CA / ACCESSWIRE / April 16, 2021 / BioTech Medics, Inc. (OTC PINK:BMCS) Announces the firm has begun operating Sumcoin Nodes directly and is exploring how to support the network with mining equipment. A significant step while BMCS continues to cooperate with FINRA for the Company's name change approval from Bio Tech Medics to BMCS Sumcoin Index Fund Inc.
According to Anthony K. Miller, CEO, "We want utilize the Sumcoin Network but also provide support to the Sumcoin network. In order to accept Sumcoin payments, BioTech Medics is now using internal and open source software for using and supporting Sumcoin. Nodes are computers which run a full core wallet on Sumcoin's network that stores the complete blockchain history and history of work by miners to verify transactions that avoid the cryptocurrency from being spent twice. I understand that a community coin depends of the efforts of the coin holder himself, so contributing Nodes and exploring how to harden the blockchain with mining equipment just makes sense.
I've been a firm believer in Sumcoin as a currency for several years now. Since Sumcoins value is predicated by an Index, it's not subject to pump and dump schemes. Sumcoins blockchain shares the security/decentralization characteristics of Bitcoin plus its speed of transactions make SUM a superior peer to peer currency in my opinion. As fiat currencies show more signs of inflation, you see Sumcoin used more and more in nearly every country directly from one person to another totalling over 24 Million transactions in its history so far. I think this is only the beginning for Sumcoin so this is a seminal moment for BioTech Medics. There's simply no other coin like Sumcoin".
The companies Sumcoin Node generated its first Public Key which is ST66djkwcpuz8j12P1eKyEuQGmdTcqFja1
Recent BMCS News
- Firm Shifts into Calcium Business Model With Acquisition • AllPennyStocks.com • 10/02/2023 03:20:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM